Ramtin Agah

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA.

Prysm Systems, Inc. engages in the provision of digital display solutions. The firm designs and manufactures Laser Phosphor Displays for large format video applications. The company was founded by Amit Jain and Roger J. Hajjar in 2005 and is headquartered in San Jose, CA.

The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ.

Part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd., Worldwide Clinical Research, Inc. provides management consulting services to the clinical research industry. The company is based in Overland Park, KS. The company was founded by Barbara J. Geiger. Worldwide Clinical Research was acquired by Clinipace, Inc., part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. from April 28, 2021 on November 09, 2009.

Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel.

Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.

Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.

Part of New York University, New York University Medical Center is a healthcare provider that offers personalized treatment for reproductive and sexual health conditions in men and women. The company is based in New York and provides emergency and urgent care at various locations, as well as Virtual Urgent Care. NYU Langone's Community Health Needs Assessment and Service Plan aims to support behavior change and disease prevention at the neighborhood level. The American company was founded by J. Ira Harris.

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.

ForSight VISION4, Inc. develops novel drug delivery therapies for treatment of retinal diseases. The company was founded on June 26, 009 and is headquartered in Menlo Park, CA.

Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation.

Fogarty Institute for Innovation is a non-profit company that believes innovation is the key to medical advancement. The company is based in Mountain View, CA. The company strives to shape the future of human health through their work. The company was founded by Thomas J. Fogarty. Andrew Cleeland has been the CEO of the company since 2017.

Perceive Biotherapeutics, Inc. is a biotech company that is focused on developing a diverse pipeline of targets and treatment modalities for various therapeutic verticals, with a particular emphasis on ophthalmology. The company is based in South San Francisco, CA. Perceive is backed by Deerfield Management and is planning to raise a series B later this year. The company was founded based on research that identified two novel protective biologies for treating retinal blindness, which were developed from collaborations in genetic science and target validation. Kristen Angela MacFarlane has been the CEO of the company since 2020.

ForSight VISION6, Inc. provides health care services. The company is headquartered in Brisbane, CA.

Spiral Therapeutics, Inc. manufactures pharmaceutical products. The firm also develops therapies for inner ear disorders. The company was founded by Hugo Peris, Justin S. Hanes and Eugene de Juan in 2016 and is headquartered in San Francisco, CA.

Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota.

Voyant Biotherapeutics LLC develops ocular therapeutics to solve age-related macular degeneration. The private company is based in Menlo Park, CA.

Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel.

Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY.

Avellino Lab USA, Inc. engages in the provision of diagnostic testing services. It focuses on developing genetic tests for eye care professionals. It also involves in research and development activities related to genetic diagnostics for the prediction and prevention of eye conditions. The company was founded by Gene Lee in 2008 and is headquartered in Menlo Park, CA.